The prognostic significance of prostate specific antigen in metastatic hormone-resistant prostate cancer.

od Fosså, S. D., Waehre, H., Paus, E.
Izdano 1992

Late recurrences of germ cell malignancies: a population-based experience over three decades

od Oldenburg, J, Alfsen, G C, Wæhre, H, Fosså, S D
Izdano 2006

Hormone resistant prostatic adenocarcinoma. An evaluation of prognostic factors in pre- and post-treatment specimens.

od Berner, A., Nesland, J. M., Waehre, H., Silde, J., Fosså, S. D.
Izdano 1993

DNA ploidy in primary testicular cancer.

od Fosså, S. D., Nesland, J. M., Pettersen, E. O., Amellem, O., Waehre, H., Heimdal, K.
Izdano 1991

Ejaculation in testicular cancer patients after post-chemotherapy retroperitoneal lymph node dissection

od Jacobsen, K D, Ous, S, Wæhre, H, Trasti, H, Stenwig, A E, Lien, H H, Aass, N, Fosså, S D
Izdano 1999

Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients

od Mu, L J, Kyte, J A, Kvalheim, G, Aamdal, S, Dueland, S, Hauser, M, Hammerstad, H, Waehre, H, Raabe, N, Gaudernack, G
Izdano 2005

Clinical significance of DNA ploidy and S-phase fraction and their relation to p53 protein, c-erbB-2 protein and HCG in operable muscle-invasive bladder cancer.

od Fosså, S. D., Berner, A. A., Jacobsen, A. B., Waehre, H., Kvarstein, B., Urnes, T., Ogreid, P., Johansen, T. E., Silde, J., Nesland, J. M.
Izdano 1993